Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Volume:79 Issue:1 Number:1 ISSN#:2564-2537
RCT
ACE Report #13822
Ace Report Cover Osteoarthritis

Safety and Efficacy of an Amniotic Suspension Allograft Injection for Symptomatic Knee OA


How to Cite

OrthoEvidence. Safety and Efficacy of an Amniotic Suspension Allograft Injection for Symptomatic Knee OA. ACE Report. 2021;79(1):1. Available from: https://myorthoevidence.com/AceReport/Report/13822

Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1

Safety and Efficacy of an Amniotic Suspension Allograft Injection Over 12 Months in a Single-Blinded, Randomized Controlled Trial for Symptomatic Osteoarthritis of the Knee.

Arthroscopy. 2021 Jul;37(7): 2246-2257.

Contributing Authors: AH Gomoll J Farr BJ Cole DC Flanigan C Lattermann BR Mandelbaum SM Strickland KR Zaslav KA Kimmerling KC Mowry

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

Two-hundred patients with moderate, symptomatic knee osteoarthritis were randomized to receive an intra-articular injection of amniotic suspension allograft (ASA; n=68), hyaluronic acid (HA; n=64) or normal saline (n=68). Outcomes of interest included the change from baseline at 12 months in the Knee Injury and Osteoarthritis Outcome Score (KOOS) subsets (pain; symptoms; activities of daily living...

CME Image

Continuing Medical Education Credits

You could be earning 0.5 CME credits for each report you read.

LEARN MORE
For Reprints and Permissions, click here

Please Login or Join to leave comments.